Company Filing History:
1 out of 67 
1 out of 11 Years Active: 2018
Title: Christa Haldrup: Innovator in Prostate Cancer Diagnostics
Introduction
Christa Haldrup is a notable inventor based in Nørre Snede, Denmark. She has made significant contributions to the field of medical diagnostics, particularly in the area of prostate cancer. Her innovative work has led to the development of methods and tools that enhance the diagnosis and prognosis of this prevalent disease.
Latest Patents
Christa Haldrup holds 1 patent for her invention titled "Biomarkers for Prostate Cancer." This patent focuses on methods for diagnosing prostate cancer and prognosing disease progression. The method involves determining the methylation levels of specific genes, including C1orf114, HAPLN3, AOX1, GAS6, ST6GALNAC3, and ZNF660. By comparing these results with a control, healthcare professionals can obtain valuable insights for diagnosing prostate cancer and assessing the condition of individuals suffering from it.
Career Highlights
Throughout her career, Christa has worked with esteemed institutions such as Aarhus Universitet and Region Midtjylland. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Torben Ørntoft and Karina Dalsgaard Sørensen. Their collaborative efforts have further advanced the research and development of innovative diagnostic tools for prostate cancer.
Conclusion
Christa Haldrup's contributions to prostate cancer diagnostics exemplify the impact of innovation in healthcare. Her work not only aids in the early detection of the disease but also enhances the understanding of its progression.